Search earnings tickers

GILD

2025Q4AMC

Gilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-02-10 · Fiscal end 2025-12-31 · Features as of 2026-02-10

← Earnings history

Street

Consensus EPS1.81

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.4%

IV front—

P/C full—

P/C front—

Features as of2026-02-10

Run-up

Close—

Ret 5d+2.8%

Ret 10d+4.4%

Ret 20d+20.1%

Ret 30d+18.1%

Print

Actual EPS

1.86Beat

Estimated EPS1.81

Actual revenue

7.9B

Surprise %+2.8%

Beat / missBeat

Beat streak 44

Beat streak 88

Reaction

1-day stock reaction+4.6%

Implied vs actual

Implied 2.4%Actual 1.1%

Gap reaction+1.1%

Day result+5.8%

Next-day upYes

Realized / IV0.47×

Post tape

Post 5d-3.0%

Post 10d-7.7%

Post volume11.4M

Vol ×10d1.41×

Vol ×20d1.37×

Post range6.7%